Cahill Represents Financing Sources in $4.20 Billion of Debt Financings, Consisting of a $1.0 Billion Notes Offering and $3.20 Billion in Credit Facilities for Syneos Health
Date: 09/28/23
Cahill represented the initial purchasers in connection with a Rule 144A/Regulation S offering of $1,000,000,000 aggregate principal amount of 9.00% senior secured notes due 2030 by Star Parent, Inc. Cahill also represented the lead arrangers in connection with a $2,700,000,000 term B credit facility and a $500,000,000 revolving credit facility for Star Parent, Inc. Proceeds from the borrowings under the credit facilities and the notes offering were used to fund the leveraged buyout of Syneos Health, Inc. by a consortium of private investment firm affiliates of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital, and to otherwise provide for working capital and general corporate purposes. Syneos Health is a leading fully integrated biopharmaceutical solutions organization.